Trinity Biotech plc - American Depositary Shares (TRIB)
TRIB moved a median of -0.13% 30 minutes after news, and -0.90% by the close. How TRIB actually reacts to news — the realized, point-in-time move the market made, measured across 292 labeled events over the last three years with zero look-ahead.
TRIB’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 41% | 253 |
| 30-min | -0.13% | 44% | 276 |
| 60-min | -1.04% | 38% | 283 |
| to close | -0.90% | 38% | 288 |
| Middle 50% of TRIB reactions | -2.85% to +1.67% |
|---|---|
| Median reaction (30-min) | -0.13% |
| Measured reactions | 292 |
Half of all Trinity Biotech plc - American Depositary Shares news events land between -2.85% and +1.67% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when TRIB moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TRIB's baseline. Nothing else.
Recent TRIB events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K TRINITY BIOTECH PLC For: Oct 02 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 6-K TRINITY BIOTECH PLC For: Sep 09 | SEC filing · Form 6-K | SEC EDGAR | +5.56% | -11.11% | |
| Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure | Press release | GlobeNewswire | +5.56% | -11.11% | |
| Form 6-K TRINITY BIOTECH PLC For: Sep 08 | SEC filing · Form 6-K | SEC EDGAR | +5.56% | -11.11% | |
| Form EFFECT TRINITY BIOTECH PLC | SEC filing · Form EFFECT | SEC EDGAR | — | -1.03% | |
| Form 6-K TRINITY BIOTECH PLC For: Aug 28 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +2.71% | |
| Form POS AM TRINITY BIOTECH PLC | SEC filing · Form POS | SEC EDGAR | +0.00% | +2.71% | |
| Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update | Press release | GlobeNewswire | +0.00% | +2.71% | |
| Form AW TRINITY BIOTECH PLC | SEC filing · Form AW | SEC EDGAR | — | -0.51% | |
| Form F-1/A TRINITY BIOTECH PLC | SEC filing · Form F-1 | SEC EDGAR | — | +0.95% | |
| Form 6-K TRINITY BIOTECH PLC For: Aug 17 | SEC filing · Form 6-K | SEC EDGAR | +0.35% | -3.37% | |
| Trinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure | Press release | GlobeNewswire | +0.35% | -3.37% | |
| Form 6-K TRINITY BIOTECH PLC For: Aug 14 | SEC filing · Form 6-K | SEC EDGAR | — | -3.56% | |
| Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement | Press release | GlobeNewswire | +7.97% | -1.52% | |
| Form 6-K TRINITY BIOTECH PLC For: Jul 22 | SEC filing · Form 6-K | SEC EDGAR | +2.26% | -2.16% | |
| Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology | Press release | GlobeNewswire | +2.26% | -2.16% | |
| Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change | Press release | GlobeNewswire | +2.26% | -2.16% | |
| Point of Care Diagnostics Market worth $31.46 billion by 2031 | MarketsandMarkets™ | Press release | PR Newswire | +1.19% | +4.23% | |
| Form 6-K TRINITY BIOTECH PLC For: Jul 02 | SEC filing · Form 6-K | SEC EDGAR | +1.09% | +7.82% | |
| New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring | Press release | GlobeNewswire | +1.09% | +7.82% | |
| Form 6-K TRINITY BIOTECH PLC For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | -1.45% | +0.83% | |
| Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling | Press release | GlobeNewswire | -1.45% | +0.83% | |
| Form 6-K TRINITY BIOTECH PLC For: Jun 29 | SEC filing · Form 6-K | SEC EDGAR | +4.70% | +3.42% | |
| Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville | Press release | GlobeNewswire | +13.17% | +10.47% | |
| Form 6-K TRINITY BIOTECH PLC For: Jun 23 | SEC filing · Form 6-K | SEC EDGAR | -8.47% | -16.60% | |
| Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market | Press release | GlobeNewswire | -8.47% | -16.60% | |
| Form 6-K TRINITY BIOTECH PLC For: Jun 18 | SEC filing · Form 6-K | SEC EDGAR | -0.36% | -0.91% | |
| Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results | Press release | GlobeNewswire | -11.32% | -22.97% | |
| Form 6-K TRINITY BIOTECH PLC For: Jun 12 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +4.18% | |
| Form EFFECT TRINITY BIOTECH PLC | SEC filing · Form EFFECT | SEC EDGAR | -0.19% | +0.30% | |
| Form 6-K TRINITY BIOTECH PLC For: Jun 05 | SEC filing · Form 6-K | SEC EDGAR | +1.74% | +3.63% | |
| Form AW TRINITY BIOTECH PLC | SEC filing · Form AW | SEC EDGAR | — | -1.68% | |
| Form POS AM TRINITY BIOTECH PLC | SEC filing · Form POS | SEC EDGAR | — | -1.68% | |
| Form F-1/A TRINITY BIOTECH PLC | SEC filing · Form F-1 | SEC EDGAR | -3.50% | -6.92% | |
| Form RW TRINITY BIOTECH PLC | SEC filing · Form RW | SEC EDGAR | -3.50% | -6.92% | |
| Form EFFECT TRINITY BIOTECH PLC | SEC filing · Form EFFECT | SEC EDGAR | -0.92% | +7.85% | |
| Form F-3 TRINITY BIOTECH PLC | SEC filing · Form F-3 | SEC EDGAR | +0.00% | +0.64% | |
| Form 6-K TRINITY BIOTECH PLC For: May 06 | SEC filing · Form 6-K | SEC EDGAR | +3.63% | -4.52% | |
| Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations | Press release | GlobeNewswire | +0.02% | +1.25% | |
| Form 20-F TRINITY BIOTECH PLC For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | +0.02% | +1.25% | |
| Form 6-K TRINITY BIOTECH PLC For: Mar 25 | SEC filing · Form 6-K | SEC EDGAR | +0.08% | +1.23% | |
| Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test | Press release | GlobeNewswire | — | — | |
| Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s Syndrome | Press release | GlobeNewswire | +0.00% | -4.83% | |
| Form 6-K TRINITY BIOTECH PLC For: Mar 16 | SEC filing · Form 6-K | SEC EDGAR | — | +3.00% | |
| Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System | Press release | GlobeNewswire | -5.47% | -5.21% | |
| Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program | Press release | GlobeNewswire | -1.16% | +6.04% | |
| Form 6-K TRINITY BIOTECH PLC For: Mar 10 | SEC filing · Form 6-K | SEC EDGAR | +1.35% | -6.66% | |
| Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform | Press release | GlobeNewswire | +1.35% | -6.66% | |
| Trinity Biotech Provides Business and Trading Update | Press release | GlobeNewswire | +1.35% | -6.66% | |
| Form EFFECT TRINITY BIOTECH PLC | SEC filing · Form EFFECT | SEC EDGAR | — | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TRIB section they belong to.
Where else TRIB is measured.
TRIB earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | 293 | +0.08% | 52% |
| Merus N.V. - Common Shares (MRUS) | 292 | +0.03% | 54% |
| CRISPR Therapeutics AG - Common Shares (CRSP) | 291 | +0.10% | 53% |
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Trinity Biotech plc - American Depositary Shares's median reaction calculated?
Every labeled TRIB news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 292 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 44% of TRIB's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TRIB's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.